Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, a key study of an Ultragenyx and Mereo drug is continuing past a second interim analysis.
Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update
Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, a key study of an Ultragenyx and Mereo drug is continuing past a second interim analysis.